The tumor stroma ratio in stage II and III colon cancer: Prognostic impact and evaluation of predictive value
Current pathological biomarkers and tumor-node-metastasis (TNM) staging provide limited precision for guiding adjuvant chemotherapy (ACT) in colon cancer. The Tumor Stroma Ratio (TSR) is a histopathological prognostic biomarker and may predict ACT benefit. This study evaluated the predictive value of TSR for...